| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Institute of Pathology CHU-B23 (O.K., F.B., H.M., N.F., C.R., V.G.), Laboratory of Radio-Immunology & Neuroendocrine-Immunology, Cell Pathology (R.G.), Histology and Cytology (M.-P.D.), Molecular Oncology (R.W.), University of Liège, B-4000 Liège 1-Sart Tilman, Belgium
Address all correspondence and requests for reprints to: Vincent Geenen, M.D., Ph.D., Institute of Pathology CHU-B23, University of Liège, B-4000 Liège 1-Sart Tilman, Belgium. E-mail: vgeenen{at}ulg.ac.be
The expression of insulin-like growth factor (IGF) and IGF receptor genes was investigated by RT-PCR during ontogeny of the murine thymus. IGF-1, IGF-1R, M6P/IGF-2R genes are expressed in the thymus both in fetal and postnatal life, whereas IGF-2 messenger RNAs (mRNAs) decline after birth but are still detectable on the seventh week. By in situ hybridization, IGF-2 transcripts were located in the outer cortex and medulla of the postnatal thymus, and on the whole surface of the epithelial-like network in the fetal thymus. The effects of anti-IGFs and IGF-receptors neutralizing Abs on the generation of pre-T cell subpopulations were then investigated using fetal thymic organ cultures (FTOC). FTOC treatment with an anti-IGF-2 mAb, an anti-IGF-1R mAb, or an anti-M6P/IGF-2R polyclonal Ab induced a blockade of T cell differentiation at the CD4-CD8- stage, as shown by a significant increase in the percentage of CD4-CD8- cells and a decrease in the percentage of CD4+CD8+ cells. Moreover, anti-IGF-2 Ab treatment induced an increase in CD8+ cells suggesting that thymic IGF-2 might have a role in determining differentiation into the CD4 or CD8 lineage. Anti-IGF-1 Ab treatment decreased the proportion in CD4-CD8- cells and increased the frequency in CD4+CD8+. FTOC treatment with anti-(pro)insulin did not exert any significant effect on T cell development. These data indicate that the intrathymic IGF-mediated signaling plays an active role in the early steps of T cell differentiation during fetal development.
This article has been cited by other articles:
![]() |
I. Hansenne, C. Renard-Charlet, R. Greimers, and V. Geenen Dendritic cell differentiation and immune tolerance to insulin-related peptides in igf2-deficient mice. J. Immunol., April 15, 2006; 176(8): 4651 - 4657. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baudler, J. Baumgartl, B. Hampel, T. Buch, A. Waisman, C. M. Snapper, W. Krone, and J. C. Bruning Insulin-Like Growth Factor-1 Controls Type 2 T Cell-Independent B Cell Response J. Immunol., May 1, 2005; 174(9): 5516 - 5525. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Wylie, D. J. Pulford, A. J. McVie-Wylie, R. A. Waterland, H. K. Evans, Y.-T. Chen, C. M. Nolan, T. C. Orton, and R. L. Jirtle Tissue-Specific Inactivation of Murine M6P/IGF2R Am. J. Pathol., January 1, 2003; 162(1): 321 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. French, S. R. Broussard, W. A. Meier, C. Minshall, S. Arkins, J. F. Zachary, R. Dantzer, and K. W. Kelley Age-Associated Loss of Bone Marrow Hematopoietic Cells Is Reversed by GH and Accompanies Thymic Reconstitution Endocrinology, February 1, 2002; 143(2): 690 - 699. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |